Exploring the Cardiovascular Benefits of GLP-1 RAs in Patient Care
GLP-1 Cardiovascular Outcome Trials (CVOT)
GLP-1 Cardiovascular Outcome Trials (CVOT)
Navigating the GLP-1 Disruption: How to Protect & Evolve Your Meal Replacement Program
It’s important to help patients understand that GLP-1 medications are valuable tools within a comprehensive strategy that also involves lifestyle change, as this approach is key to achieving long-term weight loss success.
Top 5 Must-Have Nutritional Products to Drive Sales and Client Success in Your Weight Loss Practice
Biocare® is a specialized companion beverage designed to support patients on GLP-1 weight loss medications by addressing common challenges such as digestive issues, muscle loss, and nutritional deficiencies — helping them maintain overall health and well-being. A 20% affiliate commission…
Researchers are exploring the relationship between semaglutide and cognitive function and psychiatric outcomes.
Integrating functional strength training into a GLP-1 weight loss plan could mitigate the risk of sarcopenic obesity and bone density loss.
Supporting GLP-1 patients with behavior change could improve GLP-1 adherence and long-term weight loss.
Gastroparesis, acute pancreatitis and ileus paralysis are among potential GLP-1 side effects now being empirically investigated.
GLP-1 RAs, though generally safe, do have some risks.